Member NASD/SIPC

Creation Capital LLC is a unique investment bank that specializes in the founding, funding
and development of today's breakthrough technologies in the life sciences and healthcare arenas.

We have built an impressive track record by
establishing strong relationships with a world class team of scientists, entrepreneurs and inventors. These inspired pioneers have been the impetus behind some of the greatest scientific and medical achievements in recent years. Learn More...

In The News

Orthopedic implants maker Amedica files for IPO
WASHINGTON, May 22 (Reuters) - Amedica Corp., which makes spine and joint implants, said on Tuesday it is seeking an initial public offering of as much as $74.75 million in common stock. Learn More...

Amedica Corporation Raises $13.2 million in a Series D Preferred Stock Financing
SALT LAKE CITY, May 15, 2007 - Amedica Corporation announced today that it has successfully completed a private placement of its Series D Convertible Preferred Stock, raising $13.2 million in gross proceeds. Learn More...

Testimonials

"Creation Capital has been instrumental in the success of Amedica Corporation. Not only did Creation Capital's principals, who can rely on an extensive network of contacts in the financial world, organize several significant rounds of financing; they also provided Management and the Board of Directors on numerous occasions with sound and valuable strategic advice. They have been a reliable professional resource which I would not have wanted to miss in the development of Amedica Corporation."

Max Link, Chairman of the Board
–Amedica Corporation
Former CEO and Chairman
-Centerpulse Orthopedics
Former CEO and Chairman
-Sandoz Pharmaceuticals

:: :: :: :: :: :: ::

“Having worked with Gregg Honigblum on several financial transactions over the past 15 years, I have developed a tremendous amount of respect and admiration for his fund raising abilities and financial acumen.  Gregg is a talented and professional investment banker who remains committed to his clients long after the financing has been completed.  Several of the emerging companies that I have been involved with owe a large part of their success to Gregg's early stage financings.  I look forward to working with Gregg again on our next deal."

Pete Meldrum, CEO and Co-founder of Myriad Genetics

:: :: :: :: :: :: ::

“Gregg and Michael, memories of making it all possible".

Walter Gilbert, Ph.D
Biogen Co-Founder
Nobel Laureate